Disease and treatment patterns analytics: Understand the regional disease types prevalence and incidence to gauge patient population and demand volume for specific medical diagnostics and therapeutic devices. Understand physician treatment protocols and standards of care in different countries, and reasons for selecting certain treatment modalities or pharmaceuticals over others.
Key questions: How many patients are currently suffering from a particular disease? How many patients are actually seeking treatment? What kind preventive programs are in place? How can we accurately estimate potential end demand? How do the decision makers decide between treatment options?
Market size and share analytics: Understand the true nature of the addressable market, and implement best practice frameworks to capture existing and future relevant market segment opportunities.
Key questions: Are we optimally setup to leverage on current market growth opportunities? Where are the upcoming market niches? Which segments will remain or become most profitable?
Market entry strategy: Prioritize opportunities, rank location and customer segment attractiveness; ascertain the optimal mode of entry and actuate three year growth plans supplemented by financial modelling and scenario analysis.
Key questions: What is the potential ROI of our new operation? What new competitive advantages can we derive from our new operation and can we leverage them across the entire firm? Is our current business model adequate or do we need to adapt?
Reimbursement assessment and requirements: Provide update on the ever-changing regulatory and reimbursement environment in Asia; assess any potential barriers and challenges arise from regulatory requirements that may hinder market expansion and entry.
Key questions: What is the reimbursement levels for treatments of particular illnesses? What are the likely changes in the reimbursement levels? What is the regulatory environment like in a particular country?